scholarly journals Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial

2021 ◽  
Author(s):  
Ikuo Hirano ◽  
Margaret H. Collins ◽  
David A. Katzka ◽  
Vincent A. Mukkada ◽  
Gary W. Falk ◽  
...  
Keyword(s):  
Eosinophilic Esophagitis ◽  
Oral Suspension ◽  
Phase 3

scholarly journals Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial

2021 ◽  
Author(s):  
Ikuo Hirano ◽  
Margaret H. Collins ◽  
David A. Katzka ◽  
Vincent A. Mukkada ◽  
Gary W. Falk ◽  
...  
Keyword(s):  
Eosinophilic Esophagitis ◽  
Oral Suspension ◽  
Phase 3

Fr175 TREATMENT OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS WITH OR WITHOUT CONCOMITANT THERAPIES: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION

2021 ◽  
Vol 160 (6) ◽  
pp. S-250
Author(s):  
Ikuo Hirano ◽  
David A. Katzka ◽  
Margaret H. Collins ◽  
Abigail M. Wojtowicz ◽  
Wenwen Zhang ◽  
...  
Keyword(s):  
Treatment Outcomes ◽  
Eosinophilic Esophagitis ◽  
Oral Suspension ◽  
Phase 3 ◽  
Post Hoc Analysis ◽  
Post Hoc

Fr171 LOSS OF HISTOLOGIC, SYMPTOM AND ENDOSCOPIC EFFICACY FOLLOWING TREATMENT WITHDRAWAL IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: A PHASE 3, RANDOMIZED WITHDRAWAL STUDY OF BUDESONIDE ORAL SUSPENSION

2021 ◽  
Vol 160 (6) ◽  
pp. S-247-S-248
Author(s):  
Evan S. Dellon ◽  
Margaret H. Collins ◽  
David A. Katzka ◽  
Vincent A. Mukkada ◽  
Gary W. Falk ◽  
...  
Keyword(s):  
Eosinophilic Esophagitis ◽  
Oral Suspension ◽  
Treatment Withdrawal ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document